ibrutinib,rituximab
abbvie,janssen
['mantle,(-dismantle)', 'hodgkin', ' ibru', 'lymphoma']
results from the randomized triangle trial will be presented at #ash22 efficacy &amp; safety of #ibrutinib + standard 1st-line treatment or as substitute for auto-sct in younger pts with #mcl december 13, 9:00-10:30 am cst #meded 
Independent, international experts in hematology and oncology, creating educational programmes on #lymsm and #mmsm in collaboration with COR2ED.